欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0152/001
药品名称Rivalgin 500 mg/ml solution for injection
活性成分
    • metamizole sodium monohydrate 500.0 mg
剂型Solution for injection
上市许可持有人Richter Pharma AG Feldgasse 19 4600 Wels
参考成员国 - 产品名称Czechia (CZ)
Rivalgin 500 mg/ml injekční roztok
互认成员国 - 产品名称
    • Denmark (DK)
      Rivalgin Vet.
    • Belgium (BE)
      Rivalgin 500 mg/ml
    • Iceland (IS)
      Rivalgin vet. 500 mg/ml Stungulyf, lausn handa hestum, nautgripum, svínum og hundum
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Rivalgin vet.
    • Lithuania (LT)
      Rivalgin 500 mg/ml, injekcinis tirpalas
    • Hungary (HU)
    • Bulgaria (BG)
    • Croatia (HR)
许可日期2019/07/03
最近更新日期2020/02/28
药物ATC编码
    • QN02BB02 metamizole sodium
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase